市場調查報告書

粘液去除設備市場增長,趨勢,預測(2020-2025)

Mucus Clearance Devices Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 946281
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
粘液去除設備市場增長,趨勢,預測(2020-2025) Mucus Clearance Devices Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 110 Pages
簡介

在2020年至2025年的預測期內,粘液去除劑市場預計將以約5.5%的複合年增長率增長。

  • 推動市場增長的因素是由於家庭護理環境以及對COPD和哮喘患者的增加,對粘液去除設備的需求不斷增加。 老年人口的增長和慢性病的發生率的增加將推動粘液去除設備市場的增長。哮喘和慢性阻塞性肺疾病(COPD)的患病率上升是該行業的主要驅動力之一。
  • 例如,根據CDC(美國疾病控制和預防中心)的數據,在2018年,有900萬成年人被診斷出患有慢性支氣管炎,並且對粘液去除裝置的需求很高,這推動了市場的增長。所有這些因素都可以推動全球市場增長。

該報告調查了煤泥清除設備市場,並分析了市場概況,市場增長因素和障礙因素,市場規模趨勢以及按類型,最終用戶和地區,競爭狀況以及主要公司做出的預測。我們提供有關個人資料,市場機會等的全面信息。

內容

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場增長因素
    • 由於家庭護理環境,對粘液去除裝置的需求增加
    • 患有COPD和哮喘的患者人數增加
  • 市場約束因素
    • 發展中地區和發展中地區缺乏認識
  • 波特的五力分析

第5章市場細分

  • 按產品類型
    • HFCWO設備
    • OPEP設備
    • MCA設備
    • IPV設備
    • 其他
  • 按指示
    • COPD和哮喘
    • 囊性纖維化
    • 其他
  • 按最終用戶
    • 家庭護理設置
    • 醫院和診所
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東/非洲
    • 南美洲

第6章競爭情況

  • 公司簡介
    • Allergan
    • Electromed, Inc.
    • Hill-Rom Services Inc.
    • Koninklijke Philips NV
    • Monaghan Medical Corporation
    • Respiratory Technologies, Inc.
    • Smiths Medical
    • Thayer Medical
    • VORTRAN Medical

第7章市場機會和未來趨勢

目錄
Product Code: 69924

The Mucus Clearance Devices market studied is anticipated to grow with a CAGR of nearly 5.5%, during the forecast period.

  • Certain factors that are driving the market growth include increasing demand for Airway Clearance Devices accounted by home care settings and rising patient pool suffering from COPD and asthma.
  • Increased geriatric population coupled with higher incidences of chronic conditions drive the mucus clearance devices market growth. Increasing prevalence of chronic obstructive pulmonary disease (COPD) along with asthma is one of the major driving factors for the industry.
  • For instance, according to CDC (the Centres for Disease Control and Prevention), in 2018, 9 million adults were diagnosed with chronic bronchitis which eventually leads to higher requirements for mucus clearance devices, thus fueling the market. All such factors are likely to drive the growth of the global market.

Key Market Trends

COPD and Asthma Hold Significant Share in the Global Mucus Clearance Devices Market

  • Asthma is referred to as a chronic respiratory disease that blocks the airways of the lung because of mucus production, inflammation, and tightening of muscles. Similarly, Chronic Obstructive Pulmonary Disease(COPD) is caused by the blockade in the airways further resulting in difficulty in breathing, owing to the primary cause as tobacco smoking.
  • According to the 2018 Global Asthma Report, published by the GAN Global Centre, Auckland, New Zealand, asthma is ranked 16th among the leading causes of years lived with disability and 28th among the leading causes of the burden of disease, as measured by disability-adjusted life years, across the globe. Around 300 million people have asthma worldwide, and it is likely that by 2025 a further 100 million may be affected. There is a large geographical variation in asthma prevalence, severity, and mortality. While asthma prevalence is higher in high-income countries, most asthma-related mortality occurs in low-middle income countries.

North America Dominates the Global Mucus Clearance Devices Market

  • According to the 2019 report published by the Centers for Disease Control and Prevention (CDC), 1 in 13 people has asthma. More than 25 million Americans have asthma. This is 7.7% of adults and 8.4% of children. Asthma has been increasing since the early 1980s in all age, sex, and racial groups.
  • According to the American Academy of Allergy Asthma and Immunology (AAAI), in 2016, approximately 8.3% of children in the United States were found to have asthma. Boys were to some extent more likely to have asthma than girls at a rate of 9.2% and 7.4%, respectively.
  • Asthma incidence among children increased from 8.7% in 2001 to 9.4% in 2010 and then declined to 8.3% in 2016. Although not all changes were statistically noteworthy, a similar outline was observed among the sub-demographic groups, except the Mexican/Mexican American children, among whom asthma prevalence increased from 5.1% in 2001 to 6.5% in 2016.
  • Hence, such high prevalence of asthma drives the growth in demand for mucus clearance devices across the region, thus accounting for a major share of the global market.

Competitive Landscape

The Global Mucus Clearance Devices market is competitive and consists of a few major players. Companies like Allergan, Electromed, Inc., Hill-Rom Services Inc., Koninklijke Philips N.V., Monaghan Medical Corporation, Respiratory Technologies, Inc., Smiths Medical, Thayer Medical, VORTRAN Medical., among others, hold the substantial market share in the market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Airway Clearance Devices accounted by Home Care Settings
    • 4.2.2 Rising Patient Pool Suffering from COPD and Asthma
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness in Developing and Under-developed Regions
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 HFCWO Devices
    • 5.1.2 OPEP Devices
    • 5.1.3 MCA Devices
    • 5.1.4 IPV Devices
    • 5.1.5 Others
  • 5.2 By Indication
    • 5.2.1 COPD and Asthma
    • 5.2.2 Cystic Fibrosis
    • 5.2.3 Others
  • 5.3 By End-User
    • 5.3.1 Home Care Settings
    • 5.3.2 Hospitals and Clinics
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan
    • 6.1.2 Electromed, Inc.
    • 6.1.3 Hill-Rom Services Inc.
    • 6.1.4 Koninklijke Philips N.V.
    • 6.1.5 Monaghan Medical Corporation
    • 6.1.6 Respiratory Technologies, Inc.
    • 6.1.7 Smiths Medical
    • 6.1.8 Thayer Medical
    • 6.1.9 VORTRAN Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS